Amifampridine
Back to searchMolecule Structure
Scientific Name
Amifampridine
Description of the Drug
Amifampridine is a voltage gated potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11640
http://www.drugbank.ca/drugs/DB11640
Brand Name(s)
Ruzurgi
Company Owner(s)
Catalyst Pharmaceuticals Inc, Jacobus Pharmaceutical Co Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Voltage-gated potassium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2362996 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL21273 | |||
| Human Metabolome Database | HMDB0246022 | |||
| DrugBank | DB11640 | |||
| PubChem: Thomson Pharma | 15170514 | |||
| PubChem | 5918 | |||
| Mcule | MCULE-5478459845 | |||
| NMRShiftDB | 10017792 | |||
| Nikkaji | J51.295H | |||
| PDBe | L89 | |||
| BindingDB | 50416493 | |||
| EPA CompTox Dashboard | DTXSID6046715 | |||
| DrugCentral | 4336 | |||
| ChemicalBook | CB6676074 | |||
| Guide to Pharmacology | 8032 | |||
| rxnorm | AMIFAMPRIDINE | FIRDAPSE | AMIFAMPRIDINE PHOSPHATE | RUZURGI |
| ChEBI | 135948 | |||
| ZINC | ZINC000000164000 |
